Candesartan reduces urinary fatty acid-binding protein excretion in patients with autosomal dominant polycystic kidney disease (Q46761648)

From Wikidata
Jump to navigation Jump to search
scientific article published in October 2005
edit
Language Label Description Also known as
English
Candesartan reduces urinary fatty acid-binding protein excretion in patients with autosomal dominant polycystic kidney disease
scientific article published in October 2005

    Statements

    Candesartan reduces urinary fatty acid-binding protein excretion in patients with autosomal dominant polycystic kidney disease (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit